BNTX vs REGN: Which Stock is Better?

Side-by-side comparison of BioNTech SE and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

BNTX

BioNTech SE

$88.08

REGN

Regeneron Pharmaceuticals Inc

$635.45

Key Metrics Comparison

MetricBNTXREGNWinner
Market Cap$24.26B$59.10BREGN
P/E RatioN/A13.91REGN
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze BNTX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is BNTX or REGN a better investment?

Comparing BNTX and REGN: BioNTech SE has a market cap of $24.26B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between BNTX and REGN?

BNTX (BioNTech SE) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: BNTX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: BNTX or REGN?

Both BNTX and REGN show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: BNTX or REGN?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: BNTX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $24.26B for BNTX.

Should I buy BNTX or REGN in 2026?

Both BNTX and REGN have investment merit. BNTX trades at $88.08 while REGN trades at $635.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between BNTX and REGN stock?

Key differences: Market Cap ($24.26B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy BNTX or REGN in 2026?

The choice between BNTX and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between BNTX and REGN?

BNTX (BioNTech SE) has a market cap of $24.26B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.

Popular Stock Comparisons